Rate of Genitourinary Injuries Up Among U.S. Service Men

Share this content:
Rate of Genitourinary Injuries Up Among U.S. Service Men
Rate of Genitourinary Injuries Up Among U.S. Service Men

MONDAY, Jan. 16, 2017 (HealthDay News) -- A total of 1,367 male U.S. service members deployed to Operation Iraqi Freedom/Operation Enduring Freedom sustained genitourinary injury, according to a study published in the February issue of The Journal of Urology.

Judson C. Janak, Ph.D., from the U.S. Army Institute of Surgical Research in in Fort Sam Houston, Texas, and colleagues conducted a retrospective, cross-sectional study to examine the number, nature, and severity of genitourinary injuries among male U.S. service members who were deployed to Operations Iraqi Freedom and Enduring Freedom.

The researchers found that 1,367 male U.S. service members sustained one or more genitourinary injuries from October 2001 to August 2013. Most injuries involved the external genitalia (73.2 percent), including the scrotum, testes, penis, and/or urethra (55.6, 33.0, 31.0, and 9.1 percent, respectively). At least one severe genitourinary injury was sustained by more than one-third (36.7 percent) of service members with genitourinary injury. One hundred forty-six men had loss of one or both testes, including 129 unilateral orchiectomies and 17 bilateral orchiectomies. Traumatic brain injury, pelvic fracture, colorectal injury, and low extremity amputation were common comorbid injuries (40.2, 25.0, 21.7, and 28.7 percent, respectively).

"Deployment-related genitourinary trauma is a uniquely devastating injury that has become increasingly common during the recent wars in Iraq and Afghanistan," lead investigator Lieutenant Colonel Steven J. Hudak, M.D., of the Brooke Army Medical Center in Fort Sam Houston, Texas, said in a journal news release.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »